Studies have shown that NK cell activity is significantly decreased in RA patients, which may be related to the presence of large amounts of interleukin-6 (IL-6), TNF-α, and interleukin-18 (IL-18) in their serum, which can reduce the expression of NKG2D on their surfaces [65]. The gene discussed is KLRK1; the disease is rheumatoid arthritis.